First Trust NYSE Arca Biotechnology Index Fund
256 hedge funds and large institutions have $576M invested in First Trust NYSE Arca Biotechnology Index Fund in 2024 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 55 increasing their positions, 97 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
256
Holders Change
+6
Holders Change %
+2.4%
% of All Funds
3.7%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
32
Increased
55
Reduced
97
Closed
23
Calls
$4.38M
Puts
–
Net Calls
+$4.38M
Net Calls Change
+$1.44M
Top Buyers
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
+$10.1M |
| 2 |
CWM
Congress Wealth Management
Boston,
Massachusetts
|
+$7.26M |
| 3 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$3.92M |
| 4 |
BEI
Benjamin Edwards Inc
Clayton,
Missouri
|
+$3.54M |
| 5 |
AssetMark Inc
Concord,
California
|
+$3.43M |
Top Sellers
| 1 |
Wells Fargo
San Francisco,
California
|
-$31.4M |
| 2 |
Jane Street
New York
|
-$6.49M |
| 3 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$6.04M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3.92M |
| 5 |
LPL Financial
San Diego,
California
|
-$3.82M |
